US2902402A - Thioamine anthelmintic agents - Google Patents
Thioamine anthelmintic agents Download PDFInfo
- Publication number
- US2902402A US2902402A US624509A US62450956A US2902402A US 2902402 A US2902402 A US 2902402A US 624509 A US624509 A US 624509A US 62450956 A US62450956 A US 62450956A US 2902402 A US2902402 A US 2902402A
- Authority
- US
- United States
- Prior art keywords
- piperazine
- sulfur
- poly
- thiobis
- mole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ZGZUKKMFYTUYHA-HNNXBMFYSA-N (2s)-2-amino-3-(4-phenylmethoxyphenyl)propane-1-thiol Chemical compound C1=CC(C[C@@H](CS)N)=CC=C1OCC1=CC=CC=C1 ZGZUKKMFYTUYHA-HNNXBMFYSA-N 0.000 title description 6
- 229940124339 anthelmintic agent Drugs 0.000 title description 6
- 239000000921 anthelmintic agent Substances 0.000 title description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 23
- 241001465754 Metazoa Species 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 9
- 206010061217 Infestation Diseases 0.000 claims description 8
- 230000000968 intestinal effect Effects 0.000 claims description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 164
- 229960005141 piperazine Drugs 0.000 description 80
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 74
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 46
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 42
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 30
- -1 cyanomethyl Chemical group 0.000 description 29
- 229910052717 sulfur Inorganic materials 0.000 description 26
- 239000011593 sulfur Substances 0.000 description 23
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 19
- 239000007787 solid Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 18
- 235000011121 sodium hydroxide Nutrition 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 238000001816 cooling Methods 0.000 description 13
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 13
- 150000001412 amines Chemical class 0.000 description 11
- 230000000507 anthelmentic effect Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000282898 Sus scrofa Species 0.000 description 8
- PXJJSXABGXMUSU-UHFFFAOYSA-N disulfur dichloride Chemical compound ClSSCl PXJJSXABGXMUSU-UHFFFAOYSA-N 0.000 description 8
- 244000000013 helminth Species 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 7
- 241000498255 Enterobius vermicularis Species 0.000 description 7
- 229960003237 betaine Drugs 0.000 description 7
- 206010014881 enterobiasis Diseases 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- WIJOOIFTTQXTBL-UHFFFAOYSA-N 5-ethyl-2-methylpyridin-4-amine Chemical compound CCC1=CN=C(C)C=C1N WIJOOIFTTQXTBL-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229950000688 phenothiazine Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical group 0.000 description 4
- MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 150000003335 secondary amines Chemical group 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- IDIICHZCEIGXGB-UHFFFAOYSA-N 1-piperazinecarbodithioic acid Chemical compound SC(=S)N1CCNCC1 IDIICHZCEIGXGB-UHFFFAOYSA-N 0.000 description 3
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010034145 Helminth Proteins Proteins 0.000 description 3
- 208000006968 Helminthiasis Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 241000975692 Syphacia obvelata Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 3
- QAWTYRYXDYHQNU-UHFFFAOYSA-N diazathiane Chemical class NSN QAWTYRYXDYHQNU-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 150000002019 disulfides Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012433 hydrogen halide Substances 0.000 description 3
- 229910000039 hydrogen halide Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 3
- 229920001021 polysulfide Polymers 0.000 description 3
- 239000005077 polysulfide Substances 0.000 description 3
- 150000008117 polysulfides Polymers 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ITWZZJMHNCMEOJ-UHFFFAOYSA-N 1-piperazin-1-ylsulfanylpiperazine Chemical compound C1CN(CCN1)SN1CCNCC1 ITWZZJMHNCMEOJ-UHFFFAOYSA-N 0.000 description 2
- NSMWYRLQHIXVAP-UHFFFAOYSA-N 2,5-dimethylpiperazine Chemical compound CC1CNC(C)CN1 NSMWYRLQHIXVAP-UHFFFAOYSA-N 0.000 description 2
- LTHNHFOGQMKPOV-UHFFFAOYSA-N 2-ethylhexan-1-amine Chemical compound CCCCC(CC)CN LTHNHFOGQMKPOV-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 125000004663 dialkyl amino group Chemical group 0.000 description 2
- 239000012971 dimethylpiperazine Substances 0.000 description 2
- LAWOZCWGWDVVSG-UHFFFAOYSA-N dioctylamine Chemical compound CCCCCCCCNCCCCCCCC LAWOZCWGWDVVSG-UHFFFAOYSA-N 0.000 description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- PSFDQSOCUJVVGF-UHFFFAOYSA-N harman Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C PSFDQSOCUJVVGF-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- WZZNXLLUTNONRL-UHFFFAOYSA-N piperazine-2,5-dithione Chemical compound S=C1CNC(=S)CN1 WZZNXLLUTNONRL-UHFFFAOYSA-N 0.000 description 2
- 150000004885 piperazines Chemical class 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 150000003141 primary amines Chemical group 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- NSMWYRLQHIXVAP-OLQVQODUSA-N (2r,5s)-2,5-dimethylpiperazine Chemical compound C[C@H]1CN[C@H](C)CN1 NSMWYRLQHIXVAP-OLQVQODUSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- UWOVWIIOKHRNKU-UHFFFAOYSA-N 2,6-diphenyl-4-(2,4,6-triphenylpyridin-1-ium-1-yl)phenolate Chemical compound [O-]C1=C(C=2C=CC=CC=2)C=C([N+]=2C(=CC(=CC=2C=2C=CC=CC=2)C=2C=CC=CC=2)C=2C=CC=CC=2)C=C1C1=CC=CC=C1 UWOVWIIOKHRNKU-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- BPGIOCZAQDIBPI-UHFFFAOYSA-N 2-ethoxyethanamine Chemical compound CCOCCN BPGIOCZAQDIBPI-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- SWDXALWLRYIJHK-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;piperazine Chemical compound C1CNCCN1.OC(=O)CC(O)(C(O)=O)CC(O)=O SWDXALWLRYIJHK-UHFFFAOYSA-N 0.000 description 1
- CYWGSFFHHMQKET-UHFFFAOYSA-N 2-methylsulfanylethanamine Chemical compound CSCCN CYWGSFFHHMQKET-UHFFFAOYSA-N 0.000 description 1
- XBAXAJAODIQLCI-UHFFFAOYSA-N 3-(propan-2-ylamino)propanenitrile Chemical compound CC(C)NCCC#N XBAXAJAODIQLCI-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- OEOOQMSPHMFXJL-UHFFFAOYSA-N 4-chlorobutan-1-amine Chemical compound NCCCCCl OEOOQMSPHMFXJL-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 241001408449 Asca Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- SAIKULLUBZKPDA-UHFFFAOYSA-N Bis(2-ethylhexyl) amine Chemical compound CCCCC(CC)CNCC(CC)CCCC SAIKULLUBZKPDA-UHFFFAOYSA-N 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010061201 Helminthic infection Diseases 0.000 description 1
- 229930194542 Keto Chemical group 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 208000000127 Oxyuriasis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000975704 Syphacia Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HHRFWSALGNYPHA-UHFFFAOYSA-N [N].C1CNCCN1 Chemical group [N].C1CNCCN1 HHRFWSALGNYPHA-UHFFFAOYSA-N 0.000 description 1
- PFRUBEOIWWEFOL-UHFFFAOYSA-N [N].[S] Chemical class [N].[S] PFRUBEOIWWEFOL-UHFFFAOYSA-N 0.000 description 1
- HYJODZUSLXOFNC-UHFFFAOYSA-N [S].[Cl] Chemical compound [S].[Cl] HYJODZUSLXOFNC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005122 aminoalkylamino group Chemical group 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 229940058905 antimony compound for treatment of leishmaniasis and trypanosomiasis Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 235000001729 chan in Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- PSVJDFLPZZXFDU-UHFFFAOYSA-N cyclohexen-1-amine Chemical compound NC1=CCCCC1 PSVJDFLPZZXFDU-UHFFFAOYSA-N 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 239000012990 dithiocarbamate Substances 0.000 description 1
- 150000004659 dithiocarbamates Chemical class 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093920 gynecological arsenic compound Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- JXYZHMPRERWTPM-UHFFFAOYSA-N hydron;morpholine;chloride Chemical compound Cl.C1COCCN1 JXYZHMPRERWTPM-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000005191 hydroxyalkylamino group Chemical group 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- AUZGVIFNJGOGAB-UHFFFAOYSA-N morpholine;piperazine Chemical compound C1CNCCN1.C1COCCN1 AUZGVIFNJGOGAB-UHFFFAOYSA-N 0.000 description 1
- UGUFBDAWRGLNQK-UHFFFAOYSA-N n-(2-methylpropyl)nitramide Chemical compound CC(C)CN[N+]([O-])=O UGUFBDAWRGLNQK-UHFFFAOYSA-N 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229960000718 piperazine citrate Drugs 0.000 description 1
- 229960003506 piperazine hexahydrate Drugs 0.000 description 1
- AVRVZRUEXIEGMP-UHFFFAOYSA-N piperazine;hexahydrate Chemical compound O.O.O.O.O.O.C1CNCCN1 AVRVZRUEXIEGMP-UHFFFAOYSA-N 0.000 description 1
- ZQVBNUIFDLXAFI-UHFFFAOYSA-N piperazine;hydrate;dihydrochloride Chemical compound O.[Cl-].[Cl-].C1C[NH2+]CC[NH2+]1 ZQVBNUIFDLXAFI-UHFFFAOYSA-N 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 238000011886 postmortem examination Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- CBPYOHALYYGNOE-UHFFFAOYSA-M potassium;3,5-dinitrobenzoate Chemical compound [K+].[O-]C(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 CBPYOHALYYGNOE-UHFFFAOYSA-M 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Definitions
- This invention relates to a new group of therapeutic agents. useful in. the; treatment of helminthic infections and to the therapeutic treatment of such conditions with these agents- More particularly, this invention relates to the use of N,N -thioamines and N,N-polythioamines in. the treatment of helminthiasis.
- Helininthic infections are among the most common disease conditions in the world today. They involve infestation of the body of animals with various types of parasitic worms known as. helminths. The public health significance of these organisms and the economic losses brought about by infestation of domestic animals with them has resulted in extensive research for new and more useful anthelmintics.
- A. variety of agents have been used for the treatment of this condition. These include various herb preparations such as .arecoline, aspidium, and chenopodium; heavy metal compounds including various antimony and arsenic compounds; phenolic substances including thymol and. hexylresorcinol; and many synthetic materials. Many of these have fallen into disrepute due to their toxicity, low activity, or limited anthelmintic spectrum. Indeed” there are a number of disease producing helminths that are resistant to -all presently known agents and methods. of therapy. Any addition to the anthelmintic armamentarium useful against such organisms would be indeedi welcome. Thus, a definite need exists for an elfective, inexpensive, well-tolerated anthelmintic agent andi particularly one which is elfective against these resistant species.
- piperazine either as the base or the citrate salt, has come into favor as an anthelmintic agent. Its activity, however, is limited primarily to pinworm infestations- (.oxyuriasis) and large round worm infestations (ascariasis).
- Another piperazine derivative which has been used is piperazine-l-carbodithioic betaine, but it too suffers from the disadvantage of having rather limited anthelmintic activity.
- jpiperazine is that it occasionally produces diarrhea, urticaria, vomiting, blurred vision, and general muscle weakness.
- piperazine is rapidly absorbed from the gastrointestinal tract. This of course, is disadvantageous since heliminthic infestations are frequently seated in the intestinal tract, and it is important to maintain thereapeutic levels of the drug in these organs.
- N,N-'-thio.- and.N,N'-polythioamines possess useful anthehninticactivity against a number of disease producingparasites. These substances have as a common structural feature two amino nitrogen atoms of. primary or secondary amines connected to one another: through one or more sulfur atoms.
- N-s.-N This nitrogen sulfur linkage is illustrated in the above formula wherein x is a positive integer. Those thick amines are preferred in which x is- 1 or 2, that is-the N,N'-thioamines and N,N '-dithioamines.. However, the N,N'-polythioamines. containing up to about, 8. sulfur atoms per sulfur unit are operative.
- the sulfur unit or chain may be straight or branched. By sulfur unit is meant either a sulfide, a disulfide, or a polysulfidelinleage connecting two amino nitrogen atoms i.e., S-,. SS-, -SS--S,
- the compounds useful in the present. inven: tion are: the N,N'-thioamines, and N,N--polythioamines derived from primary and. secondary amines. Amines from which the active sulfides are derived. belong to a widerange of functional types including.
- primary and secondary amines having substituents such as aliphatic hydrocarbon groups asin diethylamine, methylbutyle amine, dioctyl amine, butylarnine, allylamine, hendecen ylamine, dodecylamine, cyclohexenylamine, and octadec-- ylamine; substituted aliphatic hydrocarbon groups bears ing OH, CN, -Cl, Br, F, I, ester, ether, 'SOZ, SO3, 404,-, -S, 'NO2, NHz, 61C.
- substituents such as aliphatic hydrocarbon groups asin diethylamine, methylbutyle amine, dioctyl amine, butylarnine, allylamine, hendecen ylamine, dodecylamine, cyclohexenylamine, and octadec-- ylamine;
- hye drocarbon groups bearing OH, -CN, I, Cl, Br; F, ester, ether, ,fiSO SO SO'4.-, -S NO -N-H etc. as in. p-chloroaniline, Z-carbethdxy; L-naphthylamine, ethyl p-aminobenzoate, methyl'sulfmN methylaniline, 2ecyano-l-naphthylamine, and. minitnoe aniline; araliphatic hydrocarbon groups as in benzyl amine, naphthylmethylamine, benzhydrylamine; substituted araliphatic groups bearing.
- The, preferred. products of the present invention are thet-hioamines derived from piperazine. Since piperazine is a diainine two. or more piperazine molecules can be linked together toform thioaminesof a polymeric nature!
- piperazine thioamines as used herein applies to those:chemical compounds composed of two'or morepiperazine molecules connected through their heterocycli'c nitrogen atoms by one or more sulfur-atoms. In the case of poly-N,N-thiobis(piperazine) and poly-N,N-dithio bi's(piperazine) wherein the sulfur linkages .aretlihear;
- poly-N,N'-polythiobis(piperazine) the sulfur linkages are sometimes linear and sometimes branched.
- the structure of the polysulfides of this type is not precisely known, but they are thought to be snrnlar to the above with up to about 8 sulfur atoms between piperazine nitrogen atoms. They are obtained e1ther from the mono or disulfides of piperazine referred to above by heating with sulfur or directly from piperazme by heating with sulfur in the presence of various metal oxide catalysts such as lead oxide.
- poly- N,N'-polythiobis(piperazine) can be obtained by heating poly-N,N-dithiobis(piperazine) at 110 to 130 C.
- the sulfur monohalides and dihalides are employed um der substantially the same reaction conditions to produce poly-N,N'-dithiobis(piperazine) and poly-N,N-thiobis- (piperazine) respectively.
- the reaction is preferably carried out in an inert solvent such as benzene, toluene, xylene, liquid aliphatic hydrocarbons, and chlorinated liquid aliphatic hydrocarbons, diethyl ether, etc. Solvents such as the alcohols and ketones have been found to be less satisfactory due to interaction of them with the sulfur halide. An excess of the amine, if liquid, can be employed as the solvent.
- the reaction is carried out at temperatures up to about 100 C. but the range from about to 50 C. is preferred. Below 0 C. the reaction is rather slow while above 50 C. side reactions and decomposition sometimes occur.
- Hydrogen chloride is a by-product of the reaction when sulfur mono or dichloride is used and provision must be made for its neutralization. This is most simply accom plished by using an excess of piperazine in the reaction mixture.
- the preferred range for the piperazine to sulfur halide ratio is from about 2 to about 4 moles of piperazine per mole of sulfur halide when this mode of operation is employed. Higher ratios can be employed but there is no purpose achieved by using larger excesses of piperazine.
- the amount if piperazine charged can be reduced to about an equimolar amount.
- the ratio range for piperazine to sulfur halide is thus 1 to about 4 depending upon the neutralizing agent employed.
- a preferred method of operation involves preparing solutions of the piperazine and the sulfur halide, for instance sulfur dichloride in benzene, cooling them to about 5 C. mixing them with one another with cooling, and then .allowing theresulting solution to warm to about 25 C 4 Piperazine hydrochloride and the product precipitate.
- the piperazine hydrochloride is neutralized and separated from the poly-N,N'-thiobis(piperazine) by adding dilute (about 3-20%) aqueous sodium hydroxide, collecting the product, and washing it with water.
- Material prepared in this fashion has a melting point in the range of C. to 215 C. and corresponds in composition to a product having one atom of sulfur for each molecule if piperazine combined. It varies in color from white to pale yellow. Spectral measurements indicate that no uncombined piperazine remains in the product.
- Carbon disulfide is known to react with secondary amines to form dithiocarbamates.
- a dithiocarbamic acid betaine is formed in the case of piperazine itself. This substance is an inner salt formed between the acidic thiol group of the dithiocarbamic acid and the remaining free secondary amino group of the piperazine.
- the reaction with carbon disulfide thus provides a method for determining the number of free NH groups in a thio or dithiopiperazine molecule.
- N,N'-thioamine and N,N-polythioamines useful in the anthelmintic compositions of this invention.
- Many such compounds are known inthe art. Use of these substances in anthelmintic compositions and in the treatment of helminthiasis is also within the scope of this invention.
- Representative N,N'-thioamines and N,N-dithioamines known in the prior art have been derived from the fol piperazine,
- anhydrous piperazine be employed.
- the main impurity in the 90% piperazine which was used in many of the preparations was water. which contains a higher proportion of water is somewhat less satisfactory.
- the reaction can be carried out in the presence of a rather high proportion of Water if a water immiscible solvent is used.
- One convenient method is to allow the piperazine and sulfur halide to react in an inert organic solvent such as benzene or toluene, and to continuously neutralize the hydrogen chlorideformed in the reaction by stirring or mixing the benzene solution with a concentrated (about 3550%) aqueous: solution of sodium hydroxide or other base.
- mice with pinworm Syphacia obi/21am
- the test mice were readily infected by associating them with naturally infected mice known as source mice.
- the experimental mice acquired their infection over a number of days and therefore harbored worms in several stages of development when treated with the test compounds. This technique is described by Kam- Fai Chan in the American Journal of Hygiene, volume 56, pages 22-30 (1952).
- test mice were housed for a period of eight days with the source mice during which time they became infested with the pinworm which is similar in its host-parasite relationship to nematodes of human and veterinary importance.
- the amine sulfides under test were administered to the test mice by the oral route. A single dose daily was employed on each of the days.
- the treated mice were then sacrificed on the 11th day, about 48 hours after their last doses of the drug, and all stages of S. obvelata in the cecum were counted. Differences in worm burden between thetreated groups provided a numerical value called percent reduction in worm burden which served to express the relative antipinworm activities of the compounds.
- This table illustrates the high activity of poly-N,N-thiobis (piperazine), poly-N,N'- dithiobis(piperazine) and of several samples of poly-N,N'- polythiobis(piperazine); the effectiveness of poly-N,N- thiobis(piperazine) of relatively low dosages; the consistent activity although in somewhat larger dosages of the thioamines as a class; and the increase in activity of the thioamines over that of their parent amines.
- Poly-N,N-thiobis(piperazine) was further evaluated in swine against round worm (Ascaris lzlmbricoides), and against whipworms (T irchuris suis). infected with the above organisms were selected as test animals. The presence of infection by the above helminths was verified by fecal examination on three con secutive days prior to closing with the test compounds. In each instance, ova were found in the feces. Treated Piperazine hexahydrate Swine naturally swine were held 72 hours after dosing during which time periodic fecal examinations were made. At the end of the holding period, the animals were sacrificed and the intestine examined for the presence of ascarid's and whipworms.
- poly-N,N-thiobis(piperazin'e) proved to be active in doses of 75 mg./kg.
- the commercial anthelmintic agents above are also active against ascarids, but at higher levels.
- the increased activity of poly-N,N'-thiobis(piperazine) was particularly striking in multiple dose experiments.
- the drugs were administered in two or three consecutive daily doses.
- Poly-N,N' thiobis(piperazine) proved to be active in swine at 25 mgJkg. against'both whipworrns and ascarids when administered on three consecutive days.
- Piperazine carbodithioic acid betaine was completely inactive against these helminths when admin istered according to this regimen. It was found to be active in multiple doses of mg./kg. The activity of poly-N,N-thiobis(piperazine) at this low level is indeed a great advantage (from both physiologic and economic points of view, and in fact its use on a prophylactic basis is suggested. This material was also found to be active against nodular worms in pigs in doses of mg/kg. polyN,N'-dithiobis(piperazine) and poly-N,N'-polythiobis(piperazine) were found to be similarly active.
- piperazine thioamines of this invention were found to have a very low toxicity, to be active against ascarids and nodular worms; and significantly to be effective against whipworms Where previous. 'anthelr'nintic agents have failed. There is indeed no satisfactory agent for the treatment of whip worm in swine presently a'v'ail able although sodium fluoride has been recommended. Notwithstanding its superior activity to this material, piperazinyl sulfide has the highly important advantage over sodium fluoride of being non-toxic and safe to use.
- thioamines for the treatment of helminthiasis in animals according to the present invention involves intestinal contact of the infecting helminth with the drug. Dosage is preferably by the oral route since the major site of infection is ordinarily the intestinal tract. It is of course possible to administer these drugs rectally, but of course, this method is not as convenient as oral medication. One of the attributes of these new drugsis that they are highly effective orally. The daily dose required varies with the particular thioamine employed and the animal which is being treated.
- a single dose of 75 to 250 mg/kg. is generally sulficient'to clear the animal of the infecting parasite. Doses as low as 10-25 mg./kg. can be used if repeated on three or more consecutive days. Administration of the amino sulfides to animals can best be effected by mixing the drug with the feed. Thus, the required dose for the animal is calculated on the basis of the above formula and the drug is then blended with all or a portion of the animals daily rotation.
- the thioamines are generally supplied as the substantially pure substance for this purpose.
- a dry solid composition containing the calculated dosage of amino sulfide is blended with a convenient amount of carrier, generally from about 1 to 10 parts by weight based on the weight of th-ioamine.
- thioamines with few exceptions and in particular those derived from piperazine, are substantially insoluble in water formulation into aqueous suspensions can be readily accomplished. These suspensions possess good biological stability, perhaps due to the insolubility of the active ingredient, and can be stored on the shelf for prolonged periods without decomposition or loss of activity.
- Other vehicles such as glycerol and propylene glycol can, of course, be used. However, when aqueous vehicles are employed it is important to adjust the pH to neutral or slightly alkaline values to ensure the stability of the product.
- N,N-polythiobis(piperazine) 41% S (XXII) 53 77 92 7.
- the numerals in parentheses following the compound names refer to the experimental examples at the end of the specification. Where no numeral appears, the compound is known in the art.
- Example I POLY-N,N-THIOBIS PIPERAZINE Sulfur dichloride, 10.5 g. (0.1 mole) was dissolved in 15 ml. of benzene with cooling. A similar solution was then prepared containing 38 g. of anhydrous piperazine in 300 ml. of benzene. These two solutions were mixed with cooling at 5 C. and the temperature allowed to rise slowly to 25 C. During this time, a precipitate formed which was comprised of piperazine hydrochloride and poly-N,l-l-thiobis(piperazine). A solution of 8 g. of sodium hydroxide in 50 ml. of Water was added to neutralize the piperazine hydrochloride. The desired prod uct which remained was then collected, washed thoroughly with water, and air-dried. It was a pale yellow solid having a melting point of 214 C.
- the average molecular weight of the above material was determined by agitating a 20 g. sample of it with g. of carbon disulfide for a period of 24 hrs. at room temperature to obtain complete reaction of the poly-N, N'-thiobis(piperazine) with the carbon disulfide. The excess carbon disulfide was then removed by distillation in vacuo at room temperature and the solid residue weighed: M.P. 142 C. dec. The increase in Weight corresponded to the combination of the sample with 9 g. of carbon disulfide. Thus, 20 g. of poly-N,N-thiobis- (piperazine) is equivalent to 9 g. of carbon disulfide or 0.118 mole. Thus 20 g.
- Example II POLYN,N -DITHIOBI S (PIPERAZINE) Sulfur monochloride, 27 g. (0.2 mole), was dissolved in 100 ml. of benzene and added with stirring to a solution of 72 g. (0.8 mole) of 90.4% piperazine in 500 ml. of benzene at 10-15 C. A precipitate formed at once. A solution of 18 g. of sodium hydroxide in 500 ml. of Water was added, the precipitate collected, washed with water, and air-dried. The product obtained in this fashion was a white solid, M1. 156 C.
- Example Ill POLY-N,N-TI-IIOBIS (CIS-2,S-DIMETHYL-PIPERAZINE) Sulfur dichloride, 0.1 mole, was dissolved in 15 ml. of benzene and mixed with a solution of 46 g. (0.4 mole), of cis-2,5-dirnethylpiperazine in 300 ml. of benzene at 5 C. A precipitate formed at once. It was treated with a solution of 8 g. of sodium hydroxide in ml. of water. A clear biphasic solution resulted. The layers were separated, the aqueous layer extracted with several portions of ether, and the combined organic layers concentrated by vacuum distillation. The residue was a tan solid having a melting point of 57 C.
- Example I'V POLY Ng-N THIBIstraws-2;5-DI-ME'1HYL- PIPERAZINE) i
- the reaction wascarried out as in Example III. However, 3..S0l1d. precipitate remained after -neutralization of the reactionmixture with aqueous sodium hydroxide.
- Example V N-THIOBIS- DIQETHYLHEXYL AMINE Solutions of 51.5 g. of sulfur dichloride in .150 ml. of ether and 82 g. of di(2-ethylhexyl)amine in 750 ml. of ether were mixed with stirring and cooling. The precipitate which formed was neutralized by the addition of .aqueoussodi um hydroxide and thelayers separated. The aqueous layer-was'ext-racted several times with ether, theorga-nic layers combined, and concentrated .invacuo alfording the productas a dark brown viscousliquid having a specific gravity of 0.880 at .20" C. and refractive index 71 1.4700.
- Example VI NfN' -THIOBIS (DIETHYLAMINE) Ether solutions containing 2 molesoffdiethylamine 'in 750 ml. and 0.5.mole sulfur dichloride in 150 ml. were prepared, cooled in ice, and mixed atO-lO C. The amine hydrochloride by-product which precipitated was removed by washing with water. The ether layer was separated, dried, and concentrated yielding the product as a yellow liquid which was distilled in vacuo; B.P 80 C113 mm., sp. gr. 0.9024 at 27 C., and n 1.4613.
- DIETHYLAMINE DIETHYLAMINE
- Example VII N,N-THIOBIS (PIPERIDINE) This product was prepared by reacting 0.5 mole sulfur dichloride dissolved in ether with 1.0 mole of dodecylamine dissolved in ether at 0 to 10 C. After stirring 2 hrs., the mixture was neutralized by the additionof aqueous sodium hydroxide and the product recovered from the ether layer by distillation ofthe solvent. The product remained as a solid residue. It was washed thoroughly with a mixture of hexane and ether affording a wax-like pale yellow solid, M.P. 130 C.
- Example IX N,N'-DITHIOBIS(14(2-HYDROXYETHYL)PIPERAZINE)
- a benzene solution containing '24 g. (0.18) of sulfur monochloride was added to a mixture of 47 g. (0.36 mole) of 1-(2-hydroxyethyl)piperazine in 300 m1. of benzene at C.
- the solvent was distilled 10 under reduced pressure.
- the residue was neutralized by treatment with 500 mL of metha'nolic.
- potassium hydroxide containing 24 g. ofpotassium hydroxide and the potassium chloride filtered.
- 'Thefme'thano'l was distilled in *vacuo leaving a dark viscous liquid.
- Example XII .N,N-DITHIOBIS (MORPHOLINE) A solution of 341g. (0.25 mole) of sulfur monochlor lde was slowly added with stirring and cooling at 0-10 C. to a solution of 87 g. of morpholine in 300 ml. of ether. After -jthe-rea'ction was complete, the solvent was distilled andthe solidresidue washed with water to remove the morpholine hydrochloride. The water insoluble N,N-dithiobis(morpholine) was collected, washed with water, and dried at room temperature. It was a pale ,yellow solid, M.P. 112 C.
- Example XIII N,N"DITHIVOBIS(DIETHYLAMINE) A solution of 102 g. (0.75 mole) of sulfur monochloride in 225 m1. of ether was slowly added with stirring and cooling at 0-10 C. to a solution of 219 g. (3 moles) of diethylamine in 900 ml. of ether. The reaction mixture was then washed with water to separate the diethylamine hydrochloride, the layers separated, and the ether layer dried anddistilled. The product remained as a yellow liquid residue, 'B.P. 90 C./0.9 mm.; specific gravity at 25 C. 0.992; and refractive index N 1511.
- Example XI-V N,N-DITHIOBI S (l-DODECYLPIPERAZINE) This material was prepared from sulfur monochloride and l-dodecylpiperazine. Sulfur monochloride, 19 g. dissolved in 75 ml. of ether, and .l-dodecylpiperazine, 71 g. dissolved in ml. of ether were mixed at 0-10 C. The solvent was removed by distillation under reduced pressure and the residue washed with aqueous sodium hydroxide, 11 g. dissolved in 250 ml. of water. The product was collected by filtration, washed with water, and air-dried. It was a White wax-like solid, M.P. 44 C.
- the solid product remaining after this step was collected, washed with water, air-dried, and then washed by agitation with ethanol at 55 C. for 3 hrs.
- the slurry was cooled to -30 C., and the solid product collected, and air-dried.
- the product obtained was a brown solid, M.P. 154 C.
- Example XVI One and one half grams of poly-N,N'-thiobis(piperazine) was blended with an equal weight of lactose and sealed in a glass vial. This composition was then suitable for mixing with the daily ration of a 30 pound dog for the treatment of various helminth infestations.
- Example XVII A pig weighing 58 pounds was diagnosedas being infested with ascarids by examination of its feces by the flotation method. Seven and one half grams of poly- N,N'-thiobis(piperazine) were then mixed with the animals daily ration. The dose was entirely consumed. After about 72 hrs., no further ova could be detected in the feces. The animal was sacrificed and found to be free of the helminth on post mortem examination.
- Example XVIII The following materials were thoroughly blended and then compressed into tablets containing 75 mg. of the piperazinyl monosulfide per tablet. The total tablet Weight was 330 mg.
- Example XIX N,NTHIOBIS N-METHYLANILINE
- Example XX N,N-DITHIOBIS 3-AMINOQUINOLINE
- Sulfur monochloride 22.5 g. (0.17 mole)
- 3- arninoquinoline 48 g. (0.33 mole
- the product was received as a brown 12 Analysis.Calcd. for C H N S S, 19.85. Found: S, 19.59.
- Example XXI POLY-N,N -POLYTHIOBIS PIPERAZIN E A solution of 26 g. (0.25 mole) of sulfur dichloride in 75 ml. of hexane was added to a solution of 86 g. (1.0 mole) of anhydrous piperazine in 250 ml. of water. The mixture was neutralized with aqueous sodium hydroxide, and the product collected by filtration, washed with water, and air-dried. It was a white solid, M.P. 94 C. having a sulfur content of 49.78%.
- Example XXII POLY-N,N-'POLYTHIOBIS (PIPERAZINE) The process of Example XXI was repeated using double the quantity of sulfur dichloride dissolved in a corresponding volume of hexane. The product was recovered in a similar fashion as a white solid, M.P. 98 C. analyzing 40.72% sulfur.
- Example XXIII N ,N' -THIOBIS (LNAPHTHYLAMINE) This preparation was carried out by gradually adding with stirring and cooling a solution of 52 g. (0.5 mole) of sulfur dichloride in 150 ml. of diethyl ether to a solution of 143 g. (1.0 mole) of l-napththylamine in 850 ml. of diethyl ether.
- the amine hydrochloride was decomposed by the addition of aqueous sodium hydroxide and the precipitated naphthylamine collected, washed with water, and then with 500 ml. of methanol.
- the filtrate was diluted with an equal volume of water and the product which precipitated collected, washed with water, and airdried. It was a purple solid, M.P. 150 C.
- Example XXV N,N'-DITHIOBIS PHENOTHIAZINE
- This product was obtained as an olive-green solid, M.P. 96 C. by the substitution of 34 g. (0.25 mole) of sulfur monochloride for the sulfur dichloride in the procedure of Example XXIV.
- Example XXVI N,N-THIO BIS (2-ETHYLHEXYLAMINE) A suspension of 32 g. (1 gram atom) of sulfur and 129 g. (1 mole) Z-ethylhexylamine was heated until the evolution of hydrogen sulfide ceased. The excess 2-ethylhexylamine, 30 g., was then distilled. The product which remained was a liquid, 1 0.925.
- Example XXVII POLY-N,N -THIOBIS (4-AMINO-5-ETHYL2- METHYLPYRIDINE)
- a solution of 4 g. (0.039 mole) of sulfur dichloride in 15 ml. of diethyl ether was added gradually with stirring and cooling to a solution of 12 g. (0.078 mole) of 4 amino-5-ethyl-2-methylpyridine monohydrate in 100 ml. of diethyl ether.
- the precipitated amine hydrochloride was neutralized with aqueous sodium hydroxide and the product collected by filtration, washed with water, airdried. It was a white solid, M.P. 59 C.
- Example XX VIII N,N'-DITHIOBIS OCTADECYLAMINE
- Example XXIX Benzylamine, 18.5 g. (0.1 mole) dissolved in 50 ml. of ether was treated with 5.2 g. (0.05 mole) of sulfur dichloride in 25 ml. of ether. The mixture was then treated at room temperature with dilute aqueous sodium hydroxide to decompose hydrochloride'salts and dissolve the benzylamine. The product was recovered and tested against Syphacia obvelata in mice as described above and found to be active.
- a process for treating helminthic infestations of domestic animals comprising intestinal contact of said heliminths with a compound selected from the group consisting of N,N-thioamines and N,N'-polythioamines of the formula:
- x is a positive integer up to eight and N- is selected from the group consisting of alkylamino, dialkylamino, arninoalkylamino, hydroxyalkylamiuo, anilino, N- alkylanilino, napththylamino, quinolinylamino, pyridylamino, alkylpyridylamino, benzylamino, piperazino, alkyl piperazino, aminoalkylpiperazino, hydroxyalkylpiperazino, morpholino, and phenothiazino.
- An anthelmintic composition for domestic animals comprising as the principal anthelmintically active ingredient a compound selected from the group consisting of N,N'-thioamines and N,N'-polythioamines of the formula:
- x is a positive integer up to eight and N-- is selected from the group consisting of alkylamino, dialkylamino, aminoalkylamino, hydroxyalkylamino, anilino, N-alkylanilino, naphthylamino, quinolinylamino, pyridylamino, alkylpyridylamino, benzylamino, piperazino, alkyl piperazino, aminoalkylpiperazino, hydroxyalkylpiperazi-no, morpholino, and phenothiazino, the amount of said ingredient providing for the average daily food intake of the animal, a daily dose of at least about 10 mg./kg. of body weight.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
United States Patent 9 THIOAMINE ANTHELIVHNTIC AGENTS Joseph. A. Lambrech, (Charleston, and William H. Hensley, St..Albans,.W..Va., Robert E. Kent, Groton, Conn., and John E. Lynch, Maywood,,N.J., assignors to, Chas. Pfizer & (30., Inc., Brooklyn, N.Y., a corporation of Delaware No Drawing. Application November 27, 1956 Serial No. 624,509
8 Claims. (Cl. 167-53) This invention relates to a new group of therapeutic agents. useful in. the; treatment of helminthic infections and to the therapeutic treatment of such conditions with these agents- More particularly, this invention relates to the use of N,N -thioamines and N,N-polythioamines in. the treatment of helminthiasis.
Helininthic infections are among the most common disease conditions in the world today. They involve infestation of the body of animals with various types of parasitic worms known as. helminths. The public health significance of these organisms and the economic losses brought about by infestation of domestic animals with them has resulted in extensive research for new and more useful anthelmintics.
A. variety of agents have been used for the treatment of this condition. These include various herb preparations such as .arecoline, aspidium, and chenopodium; heavy metal compounds including various antimony and arsenic compounds; phenolic substances including thymol and. hexylresorcinol; and many synthetic materials. Many of these have fallen into disrepute due to their toxicity, low activity, or limited anthelmintic spectrum. Indeed" there are a number of disease producing helminths that are resistant to -all presently known agents and methods. of therapy. Any addition to the anthelmintic armamentarium useful against such organisms would be indeedi welcome. Thus, a definite need exists for an elfective, inexpensive, well-tolerated anthelmintic agent andi particularly one which is elfective against these resistant species.
Recently piperazine, either as the base or the citrate salt, has come into favor as an anthelmintic agent. Its activity, however, is limited primarily to pinworm infestations- (.oxyuriasis) and large round worm infestations (ascariasis). Another piperazine derivative which has been used is piperazine-l-carbodithioic betaine, but it too suffers from the disadvantage of having rather limited anthelmintic activity. Among the untoward side effects ofjpiperazine, is that it occasionally produces diarrhea, urticaria, vomiting, blurred vision, and general muscle weakness. Further, there has been some indication that piperazine is rapidly absorbed from the gastrointestinal tract. This of course, is disadvantageous since heliminthic infestations are frequently seated in the intestinal tract, and it is important to maintain thereapeutic levels of the drug in these organs.
Many derivatives of piperazine have been tested in the continuing search for a substance with broad anthelmintic activity, but these have .proven uniformly inferior to the parent substance. It is rather well accepted in the art that activity in this series is confined to iperazine, its salts, and one or two related substances. Thus, Brown, in the American Journal of Tropical Medicine and Hygiene, volume 3, page 504 (1954), reports the results of testing 32 iperazine derivatives against pinworm. Piperazine proved the most active substance and The piperazine bearing hydroxyl, keto, ester, and various nitrogen containing functions; and more complicated substituents such as aromatic and'heterocyclic rings. i
It has now been found that the class of compounds known as theN,N-'-thio.- and.N,N'-polythioamines possess useful anthehninticactivity against a number of disease producingparasites. These substances have as a common structural feature two amino nitrogen atoms of. primary or secondary amines connected to one another: through one or more sulfur atoms.
N-s.-N This nitrogen sulfur linkage is illustrated in the above formula wherein x is a positive integer. Those thick amines are preferred in which x is- 1 or 2, that is-the N,N'-thioamines and N,N '-dithioamines.. However, the N,N'-polythioamines. containing up to about, 8. sulfur atoms per sulfur unit are operative. The sulfur unit or chain may be straight or branched. By sulfur unit is meant either a sulfide, a disulfide, or a polysulfidelinleage connecting two amino nitrogen atoms i.e.,, S-,. SS-, -SS--S,
-s-s-S- i etc. Thus, the compounds useful in the present. inven: tion are: the N,N'-thioamines, and N,N--polythioamines derived from primary and. secondary amines. Amines from which the active sulfides are derived. belong to a widerange of functional types including. primary and secondary amines having substituents such as aliphatic hydrocarbon groups asin diethylamine, methylbutyle amine, dioctyl amine, butylarnine, allylamine, hendecen ylamine, dodecylamine, cyclohexenylamine, and octadec-- ylamine; substituted aliphatic hydrocarbon groups bears ing OH, CN, -Cl, Br, F, I, ester, ether, 'SOZ, SO3, 404,-, -S, 'NO2, NHz, 61C. as in ethyl (Z-cyanoethyDamine, butyl (cyanomethyl),; amine,,ethylenediamine, hydroxyethylamine, taurinea, ethoxyethylamine, methylmercaptoethylamine, ethyl iii-aminopropionate, chlorobutylamine, and. nitroisobutylamine; aromatic hydrocarbon groups as. in N-methylaniline; l:- naphthylamine, o-tolylamine; substituted aromatic. hye drocarbon groups bearing OH, -CN, I, Cl, Br; F, ester, ether, ,fiSO SO SO'4.-, -S NO -N-H etc. as in. p-chloroaniline, Z-carbethdxy; L-naphthylamine, ethyl p-aminobenzoate, methyl'sulfmN methylaniline, 2ecyano-l-naphthylamine, and. minitnoe aniline; araliphatic hydrocarbon groups as in benzyl amine, naphthylmethylamine, benzhydrylamine; substituted araliphatic groups bearing. OH, CN, Cl; Br, F, ester, ether, I, SO -SO -SO -S, NO NH etc. as in p-chlorobenzhydryl-- amine p-hydroxybenzylamine, I-aminomethyl-Z-naphthol etc.; and. heterocylic groups suchlas quinolinyl, pyridih-yl} thiazolyhlfuryl, tetrahydrofuryl, etc; The amine groups of the N,N-thioamines and. N,N-po1ythioamines= can also be, part of a1 heterocyclic system as in morpholine; piperazine, phenothiazine, thiazoline, imidazoline, etc'.
The, preferred. products of the present invention are thet-hioamines derived from piperazine. Since piperazine is a diainine two. or more piperazine molecules can be linked together toform thioaminesof a polymeric nature! The term. piperazine thioamines as used herein applies to those:chemical compounds composed of two'or morepiperazine molecules connected through their heterocycli'c nitrogen atoms by one or more sulfur-atoms. In the case of poly-N,N-thiobis(piperazine) and poly-N,N-dithio bi's(piperazine) wherein the sulfur linkages .aretlihear;
, integer from Oup to about 5, are repesentative;
In the case of poly-N,N'-polythiobis(piperazine), the sulfur linkages are sometimes linear and sometimes branched. The structure of the polysulfides of this type is not precisely known, but they are thought to be snrnlar to the above with up to about 8 sulfur atoms between piperazine nitrogen atoms. They are obtained e1ther from the mono or disulfides of piperazine referred to above by heating with sulfur or directly from piperazme by heating with sulfur in the presence of various metal oxide catalysts such as lead oxide. For example, poly- N,N'-polythiobis(piperazine) can be obtained by heating poly-N,N-dithiobis(piperazine) at 110 to 130 C. with approximately two atoms of sulfur for each disulfide linkageinvolved. Thus, in an example wherein the compound of Formula. II with n=1 was employed, one mole of this disulfide and four gram atoms of sulfur were allowed to react yielding a polysulfide of the type just described.
The sulfur monohalides and dihalides are employed um der substantially the same reaction conditions to produce poly-N,N'-dithiobis(piperazine) and poly-N,N-thiobis- (piperazine) respectively. The reaction is preferably carried out in an inert solvent such as benzene, toluene, xylene, liquid aliphatic hydrocarbons, and chlorinated liquid aliphatic hydrocarbons, diethyl ether, etc. Solvents such as the alcohols and ketones have been found to be less satisfactory due to interaction of them with the sulfur halide. An excess of the amine, if liquid, can be employed as the solvent. The reaction is carried out at temperatures up to about 100 C. but the range from about to 50 C. is preferred. Below 0 C. the reaction is rather slow while above 50 C. side reactions and decomposition sometimes occur.
Hydrogen chloride is a by-product of the reaction when sulfur mono or dichloride is used and provision must be made for its neutralization. This is most simply accom plished by using an excess of piperazine in the reaction mixture. Thus, if two moles if piperazine for each mole of sulfur mono or dihalide are employed, one mole of piperazine is available to neutralize the hydrogen halide evolved. Therefore, the preferred range for the piperazine to sulfur halide ratio is from about 2 to about 4 moles of piperazine per mole of sulfur halide when this mode of operation is employed. Higher ratios can be employed but there is no purpose achieved by using larger excesses of piperazine. Use of lower ratios of piperazine results in lower yields and in products containing a high sulfur analysis possibly due to polysulfide formation. Other arganic bases in sufficient amount to neutralize hydrogen halide evolved including pyridine, triethylamine, and other tertiary amines can be used. However, this complicates, in many instances, the isolation problem. Inorganic bases such as sodium carbonate, calcium carbonate, and potassium and sodium hydroxides can also be used. At least about a stoichiometric amount of added base is required, two moles of hydrogen halide being evolved per mole of sulfur halide reacted to form a thioamine. When a base other than piperazine of the organic or inorganic type is employed for neutralization, the amount if piperazine charged can be reduced to about an equimolar amount. The ratio range for piperazine to sulfur halide is thus 1 to about 4 depending upon the neutralizing agent employed.
A preferred method of operation involves preparing solutions of the piperazine and the sulfur halide, for instance sulfur dichloride in benzene, cooling them to about 5 C. mixing them with one another with cooling, and then .allowing theresulting solution to warm to about 25 C 4 Piperazine hydrochloride and the product precipitate. The piperazine hydrochloride is neutralized and separated from the poly-N,N'-thiobis(piperazine) by adding dilute (about 3-20%) aqueous sodium hydroxide, collecting the product, and washing it with water. Material prepared in this fashion has a melting point in the range of C. to 215 C. and corresponds in composition to a product having one atom of sulfur for each molecule if piperazine combined. It varies in color from white to pale yellow. Spectral measurements indicate that no uncombined piperazine remains in the product.
One reason suggested for the variation in melting point observed is that mixtures of piperazine thioamines of various molecular weights are obtained. Accurate determinations of the average molecular weights of these products have not been obtained since their insolubility in the solvents usually used for ebullioscopic and cryoscopic methods for determining molecular weight has prevented use of these techniques. Further, the fact that they are extremely nonvolatile has rendered mass spectrographic analysis of them unsatisfactory. Poly- N,N'-thiobis(piperazine) is stable to dilute aqueous alkali but appears to be degraded in the presence of 0.1 N hydrochloric acid at room temperature. It is slightly soluble in ethanol, isopropanol, dimethylformamide, and dimethyl sulfoxide. This apparent partial solubility may be the result of leaching out lower molecular weight components. It is virtually insoluble in water and in the non-polar organic solvents. Poly-N,N'-dithiobis piperazine has similar properties. Variations sometimes encountered in technical grade sulfur mono or dihalide also may have some effect on the composition of the product.
Some insight into the molecular structure of these substances has been obtained by end group titration with carbon disulfide. Carbon disulfide is known to react with secondary amines to form dithiocarbamates. In the case of piperazine itself, when one mole of carbon disulfide is allowed to react with one mole of piperazine, a dithiocarbamic acid betaine is formed. This substance is an inner salt formed between the acidic thiol group of the dithiocarbamic acid and the remaining free secondary amino group of the piperazine. The reaction with carbon disulfide thus provides a method for determining the number of free NH groups in a thio or dithiopiperazine molecule. If it is assumed that one mole of carbon disulfide reacts with each free NH group, then one mole of a thio or dithiopiperazine will react with two moles of carbon disulfide, one mole for each terminal amino group. Thus, by measuring the increase in weight on reaction with carbon disulfide, the molecular weight of the piperazinyl sulfide can be calculated. If it is assumed that only one terminal amino group reacts with carbon disulfide and inner salt formation occurs between the resulting dithiocarbamic acid and the remaining terminal amino group at the opposite end of the molecule, the molecular weight can be calculated in an analogous fashion. However, a value one-half as large as that as obtained on the former basis is obtained. it is thought that the former is the correct assumption, that is each terminal amino group combines with a molecule of carbon disulfide.
Employing this technique, it has been found that poly- N,N-thiobis(piperazine) melting at about 200 C. reacts with carbon disulfide in the ratio 20 g. to 9 g. CS Assuming 1 molecule of CS per terminal amino group this product then contains an average of three piperazine mollecules and two sulfide linkages, i.e. Formula I, n: I
A similar technique was used in the preparation of the other N,N'-thioamine and N,N-polythioamines useful in the anthelmintic compositions of this invention. Many such compounds are known inthe art. Use of these substances in anthelmintic compositions and in the treatment of helminthiasis is also within the scope of this invention. Representative N,N'-thioamines and N,N-dithioamines known in the prior art have been derived from the fol piperazine,
lowing aminesz diethylamine, diisopropylamine, dioctylamine, beta-isopropylaminopropionitrile, hutylaminoactonitrile, N-butjltetrahydicfurfurylamine, pyrrolidine, piperidine, pipecoline, moipholine, aniline, and butylamine. These sulfides all possess a degree of anthelmintic activity. A number of new compounds of this type also useful in this invention were prepared from the fllowing amines: cisand trans-2,S-dimethylpiperazine, N-(2- hydroxyethyhpiperazine, ethylenediamine, N-dodecyland N-(2-aminoethyl)piperazine. Experimental details for the preparation of these materials appear hereinafter.
In the preparative procedure above, it is not essential that anhydrous piperazine be employed. The main impurity in the 90% piperazine which was used in many of the preparations was water. which contains a higher proportion of water is somewhat less satisfactory. The reaction can be carried out in the presence of a rather high proportion of Water if a water immiscible solvent is used. One convenient method is to allow the piperazine and sulfur halide to react in an inert organic solvent such as benzene or toluene, and to continuously neutralize the hydrogen chlorideformed in the reaction by stirring or mixing the benzene solution with a concentrated (about 3550%) aqueous: solution of sodium hydroxide or other base. This can be done by simply placing the two immiscible solutions in a container and agitating gently during the course of the reaction. For the preliminary anthelmintic evaluation of the valuable thioamine compositions of the present invention, a natural infection of mice with pinworm (Syphacia obi/21am) was used. The test mice were readily infected by associating them with naturally infected mice known as source mice. The experimental mice acquired their infection over a number of days and therefore harbored worms in several stages of development when treated with the test compounds. This technique is described by Kam- Fai Chan in the American Journal of Hygiene, volume 56, pages 22-30 (1952). The test mice were housed for a period of eight days with the source mice during which time they became infested with the pinworm which is similar in its host-parasite relationship to nematodes of human and veterinary importance. On the 8th and 9th days after exposure to the source mice, the amine sulfides under test were administered to the test mice by the oral route. A single dose daily was employed on each of the days. The treated mice were then sacrificed on the 11th day, about 48 hours after their last doses of the drug, and all stages of S. obvelata in the cecum were counted. Differences in worm burden between thetreated groups provided a numerical value called percent reduction in worm burden which served to express the relative antipinworm activities of the compounds. Results of this test with avariety of thioamines are tabulated below. For purposes of comparison, the values obtained for piperazine citrate and piperazine carbodithioic acid betaine, known anthelmintic agents, are given. In addition, the results obtained for certain of the amines from which some of the amino sulfides and disulfides tabulated were prepared are also given. This table illustrates the high activity of poly-N,N-thiobis (piperazine), poly-N,N'- dithiobis(piperazine) and of several samples of poly-N,N'- polythiobis(piperazine); the effectiveness of poly-N,N- thiobis(piperazine) of relatively low dosages; the consistent activity although in somewhat larger dosages of the thioamines as a class; and the increase in activity of the thioamines over that of their parent amines.
Poly-N,N-thiobis(piperazine) was further evaluated in swine against round worm (Ascaris lzlmbricoides), and against whipworms (T irchuris suis). infected with the above organisms were selected as test animals. The presence of infection by the above helminths was verified by fecal examination on three con secutive days prior to closing with the test compounds. In each instance, ova were found in the feces. Treated Piperazine hexahydrate Swine naturally swine were held 72 hours after dosing during which time periodic fecal examinations were made. At the end of the holding period, the animals were sacrificed and the intestine examined for the presence of ascarid's and whipworms. Control "experiments were carried out for comparison in which infested swine were medicated with sodium fluoride, pip'erazinyl dihydrochloride monohydrate and .piperazin'e carbodithioic betaine individually. Autopsy examination revealed that sodium fluoride, piperazine dihydrochloride monohydrate, and piperazine carbodithioic acid betaine were ineffective against whipworm 'at doses of 580 trig/kg, 200 mg./kg., and 250 mg./kg. respectively. On the other hand, polyN,N-thiobis(pipe'razine) proved to be active against whipwonn in a single dose of 250 rug/kg. In ftu'ther single dose experiments with swine infested with asca'rids, poly-N,N-thiobis(piperazin'e) proved to be active in doses of 75 mg./kg. The commercial anthelmintic agents above are also active against ascarids, but at higher levels. The increased activity of poly-N,N'-thiobis(piperazine) was particularly striking in multiple dose experiments. In these experiments, the drugs were administered in two or three consecutive daily doses. Poly-N,N' thiobis(piperazine) proved to be active in swine at 25 mgJkg. against'both whipworrns and ascarids when administered on three consecutive days. Piperazine carbodithioic acid betaine was completely inactive against these helminths when admin istered according to this regimen. It was found to be active in multiple doses of mg./kg. The activity of poly-N,N-thiobis(piperazine) at this low level is indeed a great advantage (from both physiologic and economic points of view, and in fact its use on a prophylactic basis is suggested. This material was also found to be active against nodular worms in pigs in doses of mg/kg. polyN,N'-dithiobis(piperazine) and poly-N,N'-polythiobis(piperazine) were found to be similarly active.
No toxic manifestations were observed with poly-N,N- thiobis (piperazine) in the above experiments. In fact, in acute toxicity tests with mice, the LD by the intraperitoneal route was found to be 2,000 mg./ kg. This is indeed a remarkably lov toxicity when it is considered that piperazine has an intrape'ritoneal toxicity (LD of 360 mg./kg. and piperazine carbodithioic betaine 30 mg/kg. Of course, these substances are not customarily administered by this route for therapeutic purposes, but the fact that this pipera'zine thioamine has such a low toxicity "even when administered by this route reflects its safety as a therapeutic agent. The oral toxicity (LD of poly N,N-thiobis(piperazine) is also 2000 rug/kg. Low toxicities were observed for the other piperaiine thicam nes.
Thus, the piperazine thioamines of this invention were found to have a very low toxicity, to be active against ascarids and nodular worms; and significantly to be effective against whipworms Where previous. 'anthelr'nintic agents have failed. There is indeed no satisfactory agent for the treatment of whip worm in swine presently a'v'ail able although sodium fluoride has been recommended. Notwithstanding its superior activity to this material, piperazinyl sulfide has the highly important advantage over sodium fluoride of being non-toxic and safe to use.
Use of the thioamines for the treatment of helminthiasis in animals according to the present invention involves intestinal contact of the infecting helminth with the drug. Dosage is preferably by the oral route since the major site of infection is ordinarily the intestinal tract. It is of course possible to administer these drugs rectally, but of course, this method is not as convenient as oral medication. One of the attributes of these new drugsis that they are highly effective orally. The daily dose required varies with the particular thioamine employed and the animal which is being treated.
For the treatment of domestic animals, with poly-N,N- thiobis(piperazine) or poly-N,N-dithiobis(piperazine), a single dose of 75 to 250 mg/kg. is generally sulficient'to clear the animal of the infecting parasite. Doses as low as 10-25 mg./kg. can be used if repeated on three or more consecutive days. Administration of the amino sulfides to animals can best be effected by mixing the drug with the feed. Thus, the required dose for the animal is calculated on the basis of the above formula and the drug is then blended with all or a portion of the animals daily rotation. The thioamines are generally supplied as the substantially pure substance for this purpose. However, they can be diluted with inert carriers such as starch, lactose, etc. This is preferred with small animals where the total dosage is low since blending of only a few milligrams of drug with a relatively large amount of feed is inconvenient. For this purpose a dry solid composition containing the calculated dosage of amino sulfide is blended with a convenient amount of carrier, generally from about 1 to 10 parts by weight based on the weight of th-ioamine.
Since the thioamines with few exceptions and in particular those derived from piperazine, are substantially insoluble in water formulation into aqueous suspensions can be readily accomplished. These suspensions possess good biological stability, perhaps due to the insolubility of the active ingredient, and can be stored on the shelf for prolonged periods without decomposition or loss of activity. Other vehicles such as glycerol and propylene glycol can, of course, be used. However, when aqueous vehicles are employed it is important to adjust the pH to neutral or slightly alkaline values to ensure the stability of the product.
ANTHELMINTIC ACTIVITY OF REPRESENTA- TIVE THIOAMINES MEASURED AGAINST SYPHACIA OBVELATA IN MICE Per Cent Reduction in Worm Burden at Various Dosages (dosage levels in mgJkg.) Compound 1. Piperazine 40 60 95 99 2. Piperazlne Carbodithioic Betaine. 79 85 91 100 3. Poly-N N-thiobis(piperazine) (1) 51 86 95 99 4. Poly- ,N dithiobis(piperazine) (II) 41 83 9O 5. Poly N, N polythiobis (piperaziue) 50% S (XXI) 80 6. Poly-N,N-polythiobis(piperazine) 41% S (XXII) 53 77 92 7. N,N-Thiobis(diethylamine) (VI) 52 67 8. N,N-Dithiobis(diethylamine) (XIII) 53 9. N, N-Thiobis(di-2-ethylhexyl) amine (V) 54 60 10. N351; hiobis(2-etl1ylhexylamine) 46 11. Poly N,N thiobis(ethy1enedia mine) (X) 54 59 12. N ,N-Dithiobis (oetadecylarnme) (XXVIII) 46 13. Ois-2,5-Dimethylpiperazine 0 0 0 0 0 14. Poly N,N thiobis(eis 2,5 dimethylpiperazine) (III) 36 15. N,N-Thiobis(morpholine) 50 16. N,N-Dithiobis(morpholine) (XII). 48 17. N,N-Thiobis(piperidine) (VII) 56 18. 1-(2-Arninoethyl)piperazine 0 0 19. Poly N,N dithiobisfl (2 aminoethybpiperazine) (XV) 21 39 20. 1-(2-Hydroxyethyl)piperazine 0 0 0 0 0 21. N,N Dithiolois (l 2 hydroxyethyl)piperazine (IX) 14 20 22. N,N-Thiobis(1dodecy1piperazine) (XI) 34 23. N,N-Thiolois(N-nnethlyanalme) XIX 32 75 26. N,N-Thiobis(phenothiazine) XXIV 40 27. N,N-Dithiobis (phenothiazine) (XXV) 36 28. N,N- Thiobis (4 amino-5-ethyl 2 methylpyridine) (XXVII) 52 1 The numerals in parentheses following the compound names refer to the experimental examples at the end of the specification. Where no numeral appears, the compound is known in the art.
2 At dosage levels of 15.6, 7.8, and 3.9 rug/kg. reduction values of 57% 45%, and 28% were obtained. With piperazine, no activity was noted at these levels.
The following examples are provided to illustrate specific methods for the synthesis of the thioamines, their compounding into pharmaceutical preparations, and their administration to animals. They are, however, not to be construed as limiting the scope of the invention in any way.
Example I POLY-N,N-THIOBIS PIPERAZINE) Sulfur dichloride, 10.5 g. (0.1 mole) was dissolved in 15 ml. of benzene with cooling. A similar solution was then prepared containing 38 g. of anhydrous piperazine in 300 ml. of benzene. These two solutions were mixed with cooling at 5 C. and the temperature allowed to rise slowly to 25 C. During this time, a precipitate formed which was comprised of piperazine hydrochloride and poly-N,l-l-thiobis(piperazine). A solution of 8 g. of sodium hydroxide in 50 ml. of Water was added to neutralize the piperazine hydrochloride. The desired prod uct which remained was then collected, washed thoroughly with water, and air-dried. It was a pale yellow solid having a melting point of 214 C.
Analysis.Calcd. for C H N S: C, 41.37; H, 6.8; N, 24.13; S, 27.6. Found: C, 39.84; H, 7.64; N, 23.36; S, 28.68.
The average molecular weight of the above material was determined by agitating a 20 g. sample of it with g. of carbon disulfide for a period of 24 hrs. at room temperature to obtain complete reaction of the poly-N, N'-thiobis(piperazine) with the carbon disulfide. The excess carbon disulfide was then removed by distillation in vacuo at room temperature and the solid residue weighed: M.P. 142 C. dec. The increase in Weight corresponded to the combination of the sample with 9 g. of carbon disulfide. Thus, 20 g. of poly-N,N-thiobis- (piperazine) is equivalent to 9 g. of carbon disulfide or 0.118 mole. Thus 20 g. corresponds to 0.059 mole and the average molecular weight 339. This corresponds to a linear product made up of 3 molecules of piperazine and two atoms of sulfur connected to one another through nitrogen sulfur bonds, M.W. 318. The following structure is therefore proposed for the carbon disulfide adduct.
Analysis.Calcd. for C H N S N, 17.87. Found: N, 17.33.
Example II POLYN,N -DITHIOBI S (PIPERAZINE) Sulfur monochloride, 27 g. (0.2 mole), was dissolved in 100 ml. of benzene and added with stirring to a solution of 72 g. (0.8 mole) of 90.4% piperazine in 500 ml. of benzene at 10-15 C. A precipitate formed at once. A solution of 18 g. of sodium hydroxide in 500 ml. of Water was added, the precipitate collected, washed with water, and air-dried. The product obtained in this fashion was a white solid, M1. 156 C.
Analysis.Calcd. for C H N S N, 18.9. Found: N, 18.25.
Example Ill POLY-N,N-TI-IIOBIS (CIS-2,S-DIMETHYL-PIPERAZINE) Sulfur dichloride, 0.1 mole, was dissolved in 15 ml. of benzene and mixed with a solution of 46 g. (0.4 mole), of cis-2,5-dirnethylpiperazine in 300 ml. of benzene at 5 C. A precipitate formed at once. It was treated with a solution of 8 g. of sodium hydroxide in ml. of water. A clear biphasic solution resulted. The layers were separated, the aqueous layer extracted with several portions of ether, and the combined organic layers concentrated by vacuum distillation. The residue was a tan solid having a melting point of 57 C.
assa-402 Xhdlysisr-Caflcd for CfImNQSl N, 19.4. "Found: N, 18.47. Example I'V POLY=Ng-N THIBIstraws-2;5-DI-ME'1HYL- PIPERAZINE) i The reaction wascarried out as in Example III. However, 3..S0l1d. precipitate remained after -neutralization of the reactionmixture with aqueous sodium hydroxide.
This was collected, washed with water, and air-dried. The poly N,N-thiobis(:trans 2,5-dimethylpiperazine) :so obtained was a cream colored solid, 204 C.
Analysis.-Calcd. for G l-1 N 82 N, 19.4. Found: N, 19.09.
This substance was tested in the fashion described above and found to be active against pinworm in mice.
. Example V ,N-THIOBIS- DIQETHYLHEXYL AMINE Solutions of 51.5 g. of sulfur dichloride in .150 ml. of ether and 82 g. of di(2-ethylhexyl)amine in 750 ml. of ether were mixed with stirring and cooling. The precipitate which formed was neutralized by the addition of .aqueoussodi um hydroxide and thelayers separated. The aqueous layer-was'ext-racted several times with ether, theorga-nic layers combined, and concentrated .invacuo alfording the productas a dark brown viscousliquid having a specific gravity of 0.880 at .20" C. and refractive index 71 1.4700.
Example VI NfN' -THIOBIS (DIETHYLAMINE) Ether solutions containing 2 molesoffdiethylamine 'in 750 ml. and 0.5.mole sulfur dichloride in 150 ml. were prepared, cooled in ice, and mixed atO-lO C. The amine hydrochloride by-product which precipitated was removed by washing with water. The ether layer was separated, dried, and concentrated yielding the product as a yellow liquid which was distilled in vacuo; B.P 80 C113 mm., sp. gr. 0.9024 at 27 C., and n 1.4613.
Example VII N,N-THIOBIS (PIPERIDINE) This product was prepared by reacting 0.5 mole sulfur dichloride dissolved in ether with 1.0 mole of dodecylamine dissolved in ether at 0 to 10 C. After stirring 2 hrs., the mixture was neutralized by the additionof aqueous sodium hydroxide and the product recovered from the ether layer by distillation ofthe solvent. The product remained as a solid residue. It was washed thoroughly with a mixture of hexane and ether affording a wax-like pale yellow solid, M.P. 130 C.
Analysis.-Calcd. for C H N S: N, 7.0; S, 8.0. Found: N, 6.94; S, 8.07.
This compound was tested as described above and found tobe active against pinworm in mice.
Example IX N,N'-DITHIOBIS(14(2-HYDROXYETHYL)PIPERAZINE) A benzene solution containing '24 g. (0.18) of sulfur monochloride was added to a mixture of 47 g. (0.36 mole) of 1-(2-hydroxyethyl)piperazine in 300 m1. of benzene at C. After stirring for a period to permit the reaction to be completed the solvent was distilled 10 under reduced pressure. The residue was neutralized by treatment with 500 mL of metha'nolic. potassium hydroxide containing 24 g. ofpotassium hydroxide and the potassium chloride filtered. 'Thefme'thano'l was distilled in *vacuo leaving a dark viscous liquid.
. collected by" filtration, and "the ethylenediamine *monosulflde separated by leaching the ethyl'enediamin'e lrydrochloride from it with water. The flight brownsolid was air-dried, M.P. 98 C.
' Example XI. N,N'-THIOBIS(l-DODECYLPIPERAZINE) Sulfur chloride, 10 .g. (0.1 mole), was added with stirring and cooling at '0'to 10 C. to an etheral solution of 50 g. of l-dodecylpiperazine. The reaction was allowedto come to completion by mixing for a brief period, and the solventrernoved byevaporation under reduced pressure. The aminehydrochloride by-product was then removed by washing with a solution of 8g. of sodium hydroxide in m1. of water, and the precipitated product was isolated by filtration and washed with water. The air-dried material was a white wax+like soli'd, M.P. 46-48 :C. t
Analysis.Ca'1cd. for C H N S: N, 10.4; S, 5.96. Found: N, l0.07;lS, 6.52.
Example XII .N,N-DITHIOBIS (MORPHOLINE) A solution of 341g. (0.25 mole) of sulfur monochlor lde was slowly added with stirring and cooling at 0-10 C. to a solution of 87 g. of morpholine in 300 ml. of ether. After -jthe-rea'ction was complete, the solvent was distilled andthe solidresidue washed with water to remove the morpholine hydrochloride. The water insoluble N,N-dithiobis(morpholine) was collected, washed with water, and dried at room temperature. It was a pale ,yellow solid, M.P. 112 C.
Example XIII N,N"DITHIVOBIS(DIETHYLAMINE) A solution of 102 g. (0.75 mole) of sulfur monochloride in 225 m1. of ether was slowly added with stirring and cooling at 0-10 C. to a solution of 219 g. (3 moles) of diethylamine in 900 ml. of ether. The reaction mixture was then washed with water to separate the diethylamine hydrochloride, the layers separated, and the ether layer dried anddistilled. The product remained as a yellow liquid residue, 'B.P. 90 C./0.9 mm.; specific gravity at 25 C. 0.992; and refractive index N 1511.
Example XI-V N,N-DITHIOBI S (l-DODECYLPIPERAZINE) This material was prepared from sulfur monochloride and l-dodecylpiperazine. Sulfur monochloride, 19 g. dissolved in 75 ml. of ether, and .l-dodecylpiperazine, 71 g. dissolved in ml. of ether were mixed at 0-10 C. The solvent was removed by distillation under reduced pressure and the residue washed with aqueous sodium hydroxide, 11 g. dissolved in 250 ml. of water. The product was collected by filtration, washed with water, and air-dried. It was a White wax-like solid, M.P. 44 C.
.AnalySis-Calcdifbr C H N S N, 9.8. Found: N, 9.22.
This compound was tested as described above and found to be effective against pinworm in the mouse.
11 Example XV Sulfur monochloride, 34 g., dissolved in 100ml. of
benzene was added with stirring to a solution of 65 g.
of 1-(2-aminoethyl)piperazine dissolved in 400 ml. of benzene. The temperature was maintained at 510 C. with external cooling during the addition. Following the completion of the addition the mixture was agitated while the temperature was allowed to rise to room temperature. The mixture was then heated at 50 C. for 30 minutes, cooled to 25 C., and the precipitated solid collected. The filtrate was concentrated in vacuo at 30 C. The residue obtained from this process was combined with the solid previously collected by filtration and washed with aqueous caustic, 20 g. of sodium hydroxide in 750 ml. of water. The solid product remaining after this step was collected, washed with water, air-dried, and then washed by agitation with ethanol at 55 C. for 3 hrs. The slurry was cooled to -30 C., and the solid product collected, and air-dried. The product obtained was a brown solid, M.P. 154 C.
Example XVI One and one half grams of poly-N,N'-thiobis(piperazine) was blended with an equal weight of lactose and sealed in a glass vial. This composition was then suitable for mixing with the daily ration of a 30 pound dog for the treatment of various helminth infestations.
Example XVII A pig weighing 58 pounds was diagnosedas being infested with ascarids by examination of its feces by the flotation method. Seven and one half grams of poly- N,N'-thiobis(piperazine) were then mixed with the animals daily ration. The dose was entirely consumed. After about 72 hrs., no further ova could be detected in the feces. The animal was sacrificed and found to be free of the helminth on post mortem examination.
Example XVIII The following materials were thoroughly blended and then compressed into tablets containing 75 mg. of the piperazinyl monosulfide per tablet. The total tablet Weight was 330 mg.
Gram Poly-N,N'-thiobis(piperazine) 7.5 Lactose 25.2 Magnesium stearate 0.3
Example XIX N,NTHIOBIS (N-METHYLANILINE) Example XX N,N-DITHIOBIS (3-AMINOQUINOLINE) Sulfur monochloride, 22.5 g. (0.17 mole), and 3- arninoquinoline, 48 g. (0.33 mole), were allowed to react in 350 ml. of diethyl ether in a fashion similar to Example XIX. The product was received as a brown 12 Analysis.Calcd. for C H N S S, 19.85. Found: S, 19.59.
Example XXI POLY-N,N -POLYTHIOBIS PIPERAZIN E) A solution of 26 g. (0.25 mole) of sulfur dichloride in 75 ml. of hexane was added to a solution of 86 g. (1.0 mole) of anhydrous piperazine in 250 ml. of water. The mixture was neutralized with aqueous sodium hydroxide, and the product collected by filtration, washed with water, and air-dried. It was a white solid, M.P. 94 C. having a sulfur content of 49.78%.
Example XXII POLY-N,N-'POLYTHIOBIS (PIPERAZINE) The process of Example XXI was repeated using double the quantity of sulfur dichloride dissolved in a corresponding volume of hexane. The product was recovered in a similar fashion as a white solid, M.P. 98 C. analyzing 40.72% sulfur.
Example XXIII N ,N' -THIOBIS (LNAPHTHYLAMINE) This preparation was carried out by gradually adding with stirring and cooling a solution of 52 g. (0.5 mole) of sulfur dichloride in 150 ml. of diethyl ether to a solution of 143 g. (1.0 mole) of l-napththylamine in 850 ml. of diethyl ether. The amine hydrochloride was decomposed by the addition of aqueous sodium hydroxide and the precipitated naphthylamine collected, washed with water, and then with 500 ml. of methanol. The filtrate was diluted with an equal volume of water and the product which precipitated collected, washed with water, and airdried. It was a purple solid, M.P. 150 C.
Eaxmple XXIV N,N-THIOBIS (PHENOTHIAZINE) A solution of 26 g. (0.25 mole) of sulfur dichloride in 75 ml. of diethyl ether was gradually mixed While stirring and cooling with a solution of 100 g. (0.5 mole) of phenothiazine in 425 ml. of diethyl ether. The reaction mixture neutralized with aqueous sodium hydroxide and the precipitated amine collected. The ether filtrate was evaporated to dryness yielding the product which was washed with water, air-dried. It was a pea-green solid, M.P. 134 C.
Example XXV N,N'-DITHIOBIS (PHENOTHIAZINE) This product was obtained as an olive-green solid, M.P. 96 C. by the substitution of 34 g. (0.25 mole) of sulfur monochloride for the sulfur dichloride in the procedure of Example XXIV.
Example XXVI N,N-THIO BIS (2-ETHYLHEXYLAMINE) A suspension of 32 g. (1 gram atom) of sulfur and 129 g. (1 mole) Z-ethylhexylamine was heated until the evolution of hydrogen sulfide ceased. The excess 2-ethylhexylamine, 30 g., was then distilled. The product which remained was a liquid, 1 0.925.
Analysis.--Calcd. for C H N S: S, 11.1. Found: S, 12.2.
Example XXVII POLY-N,N -THIOBIS (4-AMINO-5-ETHYL2- METHYLPYRIDINE) A solution of 4 g. (0.039 mole) of sulfur dichloride in 15 ml. of diethyl ether was added gradually with stirring and cooling to a solution of 12 g. (0.078 mole) of 4 amino-5-ethyl-2-methylpyridine monohydrate in 100 ml. of diethyl ether. The precipitated amine hydrochloride was neutralized with aqueous sodium hydroxide and the product collected by filtration, washed with water, airdried. It was a white solid, M.P. 59 C.
Example XX VIII N,N'-DITHIOBIS (OCTADECYLAMINE) A solution 67.5 g. (0.5 mole) sulfur monochloride in 250 m1. of diethyl ether was gradually added with stirring and cooling to a solution of 279 g. (1 mole) of octadecylamine in 150 ml. of diethyl ether. Methanol, 1.1 l. was added to aid in stirring. The amine hydrochloride was neutralized with methanolic potassium hydroxide. The mixture was then evaporated to dryness on a steam bath and air-dried yielding a waxy-brown solid M.P. 72 C.
Example XXIX Benzylamine, 18.5 g. (0.1 mole) dissolved in 50 ml. of ether was treated with 5.2 g. (0.05 mole) of sulfur dichloride in 25 ml. of ether. The mixture was then treated at room temperature with dilute aqueous sodium hydroxide to decompose hydrochloride'salts and dissolve the benzylamine. The product was recovered and tested against Syphacia obvelata in mice as described above and found to be active.
What is claimed is:
1. A process for treating helminthic infestations of domestic animals comprising intestinal contact of said heliminths with a compound selected from the group consisting of N,N-thioamines and N,N'-polythioamines of the formula:
wherein x is a positive integer up to eight and N- is selected from the group consisting of alkylamino, dialkylamino, arninoalkylamino, hydroxyalkylamiuo, anilino, N- alkylanilino, napththylamino, quinolinylamino, pyridylamino, alkylpyridylamino, benzylamino, piperazino, alkyl piperazino, aminoalkylpiperazino, hydroxyalkylpiperazino, morpholino, and phenothiazino.
2. The process of claim 1 wherein N- is piperazino.
3. The process of claim 1 wherein x is two and N- is piperazino.
4. The process of claim 1 wherein said domestic animals receive a daily dose of at least about mg./kg. of body weight of said compound.
5. The process of claim 1 wherein said domestic animal receives, in dosage unit form, a composition con- 14 taining a significant amount of a pharmaceutical carrier and at least about 35 mg. of said compound.
6. The process of claim 5 wherein the minimum daily dosage received by said domestic animal is at least about 10 mg./ kg. of body weight.
7. An anthelmintic composition for domestic animals comprising as the principal anthelmintically active ingredient a compound selected from the group consisting of N,N'-thioamines and N,N'-polythioamines of the formula:
wherein x is a positive integer up to eight and N-- is selected from the group consisting of alkylamino, dialkylamino, aminoalkylamino, hydroxyalkylamino, anilino, N-alkylanilino, naphthylamino, quinolinylamino, pyridylamino, alkylpyridylamino, benzylamino, piperazino, alkyl piperazino, aminoalkylpiperazino, hydroxyalkylpiperazi-no, morpholino, and phenothiazino, the amount of said ingredient providing for the average daily food intake of the animal, a daily dose of at least about 10 mg./kg. of body weight.
References Cited in the file of this patent UNITED STATES PATENTS 2,766,236 Harman Oct. 9, 1956 OTHER REFERENCES White: Brit. Med. J. No. 4839, October 3, 1953, p. 755.
Claims (1)
1. A PROCESS FOR TREATING HELMINTHIC INFESTATIONS OF DOMESTIC ANIMALS COMPRISING INTESTINAL CONTACT OF SAID HELIMINTHS WITH A COMPOUND SELECTED FROM THE GROUP CONSISTING OF N,N''-THIOAMINES AND N,N''-POLYTHIOAMINES OF THE FORMULA:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US624509A US2902402A (en) | 1956-11-27 | 1956-11-27 | Thioamine anthelmintic agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US624509A US2902402A (en) | 1956-11-27 | 1956-11-27 | Thioamine anthelmintic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2902402A true US2902402A (en) | 1959-09-01 |
Family
ID=24502273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US624509A Expired - Lifetime US2902402A (en) | 1956-11-27 | 1956-11-27 | Thioamine anthelmintic agents |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2902402A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3224938A (en) * | 1961-01-20 | 1965-12-21 | Geigy Ag J R | Anthelmintic compositions and method of employing same |
| US3928340A (en) * | 1972-06-26 | 1975-12-23 | Goodyear Tire & Rubber | N-{8 (Substituted amino) thio{9 -imides |
| US9884948B2 (en) * | 2015-10-22 | 2018-02-06 | International Business Machines Corporation | Porous materials and method of making porous materials |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2766236A (en) * | 1954-02-25 | 1956-10-09 | Monsanto Chemicals | Preparing n-thioamines |
-
1956
- 1956-11-27 US US624509A patent/US2902402A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2766236A (en) * | 1954-02-25 | 1956-10-09 | Monsanto Chemicals | Preparing n-thioamines |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3224938A (en) * | 1961-01-20 | 1965-12-21 | Geigy Ag J R | Anthelmintic compositions and method of employing same |
| US3928340A (en) * | 1972-06-26 | 1975-12-23 | Goodyear Tire & Rubber | N-{8 (Substituted amino) thio{9 -imides |
| US9884948B2 (en) * | 2015-10-22 | 2018-02-06 | International Business Machines Corporation | Porous materials and method of making porous materials |
| US10557008B2 (en) | 2015-10-22 | 2020-02-11 | International Business Machines Corporation | Porous materials and method of making porous materials |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schroeder | Thioureas | |
| US3960949A (en) | 1,2-Biguanides | |
| Razdan et al. | A new class of antimalarial drugs: derivatives of benzothiopyrans | |
| US3769427A (en) | Pharmaceutical compositions and methods of using same | |
| US3769295A (en) | Nitrofuryl derivatives of 5-substituted isoxazolines | |
| US2902402A (en) | Thioamine anthelmintic agents | |
| Dunbar et al. | Reactions of thiolsulfonates with amines | |
| Cain et al. | Potential antitumor agents. 23. 4'-(9-Acridinylamino) alkanesulfonanilide congeners bearing hydrophilic functionality | |
| Cavallito et al. | Bis-ammonium salts. Derivatives of fluorene, carbazole and phenothiazine | |
| GROGAN et al. | DITHIOLS AND DERIVATIVES1 | |
| DE2142912A1 (en) | New bis-benzopyran compounds and processes for their preparation | |
| Van Heyningen et al. | The chemistry of cephalosporins. IV. Acetoxyl replacements with xanthates and dithiocarbamates | |
| DE3873997T2 (en) | 1-ALKYL-1-SULFONYL-2-ALKOXYCARBONYLSULFENYLHYDRAZINE WITH ANTI-NEOPLASMA EFFECTIVENESS. | |
| US3624086A (en) | Adamantanecarboxamidoalkanoic acid amides | |
| US3657276A (en) | Dibenzo (c f) thiazepine (1 2) compounds | |
| US3776955A (en) | Pesticidal semicarbazide and biuret derivatives | |
| US3934017A (en) | Anthelmintic composition and method utilizing isothiocyanobenzazoles active ingredients | |
| US2932644A (en) | Sulfur containing reaction products | |
| Gough et al. | CCCXXIII.—Trypanocidal action and chemical constitution. Part VIII. Derivatives of β-amino-ethyl-and γ-aminopropyl-arsinic acids | |
| US3598820A (en) | 2 - isothiouronium-methyl - 3 - carboxylic acid amido-quinoxaline - 1,4 - di-n-oxide halides and their production | |
| DE1645921B2 (en) | 2-OXO-1,3,2-OXAZAPHOSPHORINANES, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| US1760781A (en) | Manufacture of new pharmaceutical products | |
| DD159073A5 (en) | PROCESS FOR THE PREPARATION OF NEW BENZAZOLE DERIVATIVES | |
| Bardos et al. | Synthesis, Chemistry, and Preliminary Pharmacology of Arsenical Nitrogen Mustards and Structurally Related Nonalkylating Arsenicals1 | |
| US4064270A (en) | N'-(Aminoacylaminophenyl) acetamidines |